# Nuvve Holding Corp.: overview NVVE · OTC · CIK 1836875 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/nvve.md) · [Financials](/companies/nvve/financials.md) · [Filings](/companies/nvve/filings.md) · [Insiders](/companies/nvve/insiders.md) Latest reported revenue: [$1.2m](/filings/0001836875-26-000073.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001836875-26-000073). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [1,918](/filings/0001836875-25-000172.md) | [1,786 d](/filings/0001836875-26-000026.md) | [934](/filings/0001836875-26-000059.md) | [333](/filings/0001836875-26-000073.md) | [1,599](/filings/0001836875-25-000172.md) | [1,950 d](/filings/0001836875-26-000026.md) | [1,393](/filings/0001836875-26-000059.md) | [1,227](/filings/0001836875-26-000073.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(95.8%)](/filings/0001836875-25-000172.md) | [(316.4%) d](/filings/0001836875-26-000073.md) | [(597.9%)](/filings/0001836875-26-000059.md) | [(4443.8%)](/filings/0001836875-26-000073.md) | [(319.7%)](/filings/0001836875-25-000172.md) | [(343.9%) d](/filings/0001836875-26-000073.md) | [(419.5%)](/filings/0001836875-26-000059.md) | [(607.2%)](/filings/0001836875-26-000073.md) | | Net margin | % | [(86.0%)](/filings/0001836875-25-000172.md) | [(283.9%) d](/filings/0001836875-26-000026.md) | [(735.6%)](/filings/0001836875-26-000059.md) | [(4017.8%)](/filings/0001836875-26-000073.md) | [(281.9%)](/filings/0001836875-25-000172.md) | [(311.0%) d](/filings/0001836875-26-000026.md) | [(371.2%)](/filings/0001836875-26-000059.md) | [(568.6%)](/filings/0001836875-26-000073.md) | | Diluted EPS | $ per share | [(2.47)](/filings/0001836875-25-000172.md) | not reported | [(2792.31)](/filings/0001836875-26-000059.md) | [(1525.62)](/filings/0001836875-26-000073.md) | [(0.24)](/filings/0001836875-25-000172.md) | not reported | [(28.96)](/filings/0001836875-26-000059.md) | [(14.45)](/filings/0001836875-26-000073.md) | | Free cash flow | $k | [(3,508) d](/filings/0001836875-25-000172.md) | [(3,466) d](/filings/0001836875-26-000073.md) | [(1,821)](/filings/0001836875-26-000059.md) | [(5,507) d](/filings/0001836875-26-000073.md) | [(5,077) d](/filings/0001836875-25-000172.md) | [(4,252) d](/filings/0001836875-26-000073.md) | [(6,001)](/filings/0001836875-26-000059.md) | [(3,686) d](/filings/0001836875-26-000073.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [4.2](/filings/0001836875-23-000066.md) | [5.4](/filings/0001836875-24-000035.md) | [8.3](/filings/0001836875-25-000076.md) | [5.3](/filings/0001836875-26-000026.md) | [4.8](/filings/0001836875-26-000026.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(649.8%)](/filings/0001836875-23-000066.md) | [(686.7%)](/filings/0001836875-24-000108.md) | [(385.3%)](/filings/0001836875-25-000172.md) | [(387.8%)](/filings/0001836875-26-000073.md) | [(671.7%)](/filings/0001836875-26-000073.md) | | Net margin | % | [(1729.5%)](/filings/0001836875-23-000066.md) | [(447.0%)](/filings/0001836875-24-000035.md) | [(375.5%)](/filings/0001836875-25-000076.md) | [(329.1%)](/filings/0001836875-26-000026.md) | [(642.9%)](/filings/0001836875-26-000026.md) | | Diluted EPS | $ per share | [(4.37)](/filings/0001836875-23-000066.md) | [(47.55)](/filings/0001836875-24-000035.md) | [(403.57)](/filings/0001836875-25-000076.md) | [(1076.70)](/filings/0001836875-26-000026.md) | [(75.65)](/filings/0001836875-26-000026.md) | | Free cash flow | $m | [28.9](/filings/0001836875-23-000164.md) | [(34.5)](/filings/0001836875-24-000108.md) | [(21.5)](/filings/0001836875-25-000172.md) | [(15.7)](/filings/0001836875-26-000073.md) | [(16.7)](/filings/0001836875-26-000073.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/nvve/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [SBI Securities Co., Ltd.](/funds/1851815.md) | 2026-06-30 | $3 | 8 | | New +8 | ## Recent filings [All 494 filings](/companies/nvve/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-13 | 10:59 ET | [8-K](/filings/0001836875-26-000087.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001836875-26-000087 | | 2026-10-07 | 00:49 ET | [8-K](/filings/0001836875-26-000084.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001836875-26-000084 | | 2026-09-16 | 20:07 ET | [8-K](/filings/0001213900-26-100518.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-100518 | | 2026-08-27 | 20:29 ET | [8-K](/filings/0001836875-26-000079.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001836875-26-000079 | | 2026-08-14 | 21:04 ET | [10-Q](/filings/0001836875-26-000073.md) | Quarterly report, period 2026-06-30 | 0001836875-26-000073 | | 2026-08-14 | 20:33 ET | [8-K](/filings/0001836875-26-000071.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001836875-26-000071 | | 2026-07-29 | 21:57 ET | [8-K](/filings/0001836875-26-000067.md) | 1.02 Termination of a material agreement | 0001836875-26-000067 | | 2026-07-23 | 16:39 ET | [8-K](/filings/0001836875-26-000065.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001836875-26-000065 | | 2026-07-21 | 20:42 ET | [8-K](/filings/0001836875-26-000061.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001836875-26-000061 | | 2026-07-15 | 20:55 ET | [10-Q](/filings/0001836875-26-000059.md) | Quarterly report, period 2026-03-31 | 0001836875-26-000059 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001836875-26-000026.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/7edbcb05-91d2-4591-b324-a193ee5c8e10) ## About the filer - CIK: 1836875 - Tickers: NVVE - Exchange: OTC - SIC code: 3690 Miscellaneous Electrical Machinery, Equipment & Supplies - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.